Dr. Neil L. Spector, MD, was a leading physician-scientist, Duke University oncologist, and cancer researcher whose personal encounter with tick-borne disease transformed research at the intersection of oncology, Borrelia, and Bartonella.
His work bridged the gap between modern targeted cancer therapies and infectious disease, offering a framework for understanding chronic tick-borne infections.
1. Personal Experience With Lyme Carditis
Before focusing on vector-borne illnesses, Dr. Spector was an accomplished oncologist who helped pioneer targeted therapies for HER2-positive breast cancer (including the development of lapatinib).
Undiagnosed Infection: In the late 1990s, he developed debilitating symptoms including severe cardiac arrhythmias, fatigue, and neurological decline. For years, standard medical evaluations failed to identify the root cause.
Heart Failure & Transplant: By the time he was correctly diagnosed with Lyme carditis (Borrelia burgdorferi infection of the heart tissue), the spirochetes had caused irreversible damage to his heart muscle. In 2009, he underwent an emergency heart transplant at Duke University.
Advocacy: He detailed his experience as a physician becoming a critically ill patient in his memoir, Gone in a Heartbeat: A Physician’s Search for True Healing.
2. Parallels Between Cancer And Tick-Borne Diseases
Following his recovery, Dr. Spector redirected his research group at Duke to apply oncology principles to tick-borne pathogens, identifying several biological and clinical overlaps.
A. Precision Medicine Vs. Broad-Spectrum Antibiotics
Dr. Spector noted that infectious disease medicine relied heavily on broad-spectrum antibiotics—a strategy reminiscent of early, non-specific chemotherapy in oncology. He advocated applying modern precision medicine, developing drugs designed to target specific, essential proteins and enzymes within Borrelia and Bartonella without disrupting the human microbiome.
B. Bartonella, Endothelial Cells, And Angiogenesis
As a cancer researcher, Dr. Spector paid close attention to Bartonella species because of their affinity for host endothelial cells (the lining of blood vessels):
Bartonella bacteria induce the production of Vascular Endothelial Growth Factor (VEGF), triggering new blood vessel formation (angiogenesis).
This process mimics tumor angiogenesis—the mechanism solid tumors use to grow a blood supply—highlighting how Bartonella alters host cellular pathways in ways similar to oncogenic processes.
C. Diagnostic Failures
In oncology, staging and treatment decisions depend on direct molecular detection (biopsies, genomic sequencing, tumor markers). Dr. Spector criticized traditional tick-borne disease diagnostics for relying almost exclusively on indirect antibody tests (ELISA/Western Blot), which often fail in immunosuppressed or chronically infected patients, arguing instead for direct molecular diagnostics.
3. Translational Research And Legacy
At Duke University, Dr. Spector collaborated with molecular pharmacologists (such as Dr. Timothy Haystead) to screen high-throughput compound libraries against Borrelia burgdorferi and Bartonella henselae.
Their team sought small-molecule inhibitors targeting bacterial heat shock proteins (like Hsp90 equivalents) and essential kinase pathways to develop narrow-spectrum therapies designed to eradicate persistent forms of these bacteria.
Dr. Spector passed away in June 2020, but his work established research programs focused on applying precision cancer science to chronic vector-borne infections.